Oryx Dental Software
Oryx Dental Software provides dental practice management software that combines clinical, imaging, patient communication, and practice management tools.
Founded
2016Oryx Dental Software provides dental practice management software that combines clinical, imaging, patient communication, and practice management tools.
Oryx’s strongest position against Open Dental is a lower-friction, bundled clinical workflow rather than an established customization ecosystem. In 2026 Oryx delivers a cloud-native platform with integrated FDA-cleared imaging and guided charting; Open Dental offers extensive customization but is typically deployed on local servers or hosted environments and relies on third-party imaging, while Oryx Imaging received FDA 510(k) clearance in May 2022.
Oryx’s distribution and adoption evidence strengthens that product differentiation, though it does not yet establish market leadership. In June 2026, the Academy of General Dentistry made Oryx the first dental practice-management platform recognized as a member benefit provider, reaching an association that serves nearly 40,000 dentists; by August 2026, Oryx reported more than 15,000 clinicians and support for over 7 million patients.
Open Dental can beat Oryx for practices that prize open-source control, low initial cost, and deep customization over bundled convenience. In 2026, Open Dental’s stated first-year base starts around $179 per location monthly, and its extensive plugin ecosystem permits practice-specific configurations; Oryx’s plans start at $650 monthly and emphasize a packaged cloud service, making its value proposition less compelling if a buyer does not need integrated imaging and workflows.
Oryx also has less demonstrated scale than broad incumbent categories despite strong recent growth. Its August 2026 report of 15,000 clinicians and 7 million patients supported is material traction, but does not resolve whether third-party integrations, local control, or mature deployment options offered by alternatives constrain conversion among technically sophisticated offices.
Oryx competes most directly with Open Dental by trading Open Dental’s open-source flexibility for a cloud-native, more integrated workflow; Curve Dental and Dentrix Ascend are adjacent cloud alternatives to the same practice-management buyer. In 2026 Oryx’s native FDA-cleared imaging and guided charting contrast with Open Dental’s third-party imaging and customizable, often server-based deployment; Oryx Imaging received FDA 510(k) clearance in May 2022.
Oryx’s strongest evidenced growth engine is converting the shift from on-premise dental systems to cloud workflows into a broader, more visible platform sale against Open Dental and legacy vendors. In August 2026 it ranked #863 overall and #81 in software on the Inc. 5000 for a third consecutive year, reported 62 employees, more than 15,000 clinicians, and use supporting over 7 million patients; its 2026 product launches included AI charting, Patient Tracker, and Clinical Hub.
Association-led distribution could widen reach beyond direct demos, although conversion from access to paid adoption remains the key test. In June 2026, the Academy of General Dentistry offered the platform at preferred rates to nearly 40,000 members, and Oryx also partnered with Seattle Study Club in 2026; continued rank and adoption growth would support the thesis that clinical integration translates into durable demand.
The shift toward cloud delivery and AI-assisted workflows appears to strengthen Oryx’s position against server-centered alternatives, but adoption of those features is not evidence that category demand is captured by Oryx alone. Its August 2026 Inc. 5000 ranking (#863 overall, #81 in software) marked a third consecutive appearance, and the company reported more than 15,000 clinicians and support for over 7 million patients; its May 2022 FDA clearance also gave Oryx a regulated imaging product within the cloud platform.
Oryx’s investment case is a growing, dentist-founded platform that bundles clinical infrastructure and practice administration, with a plausible advantage over Open Dental for buyers valuing cloud delivery and lower vendor sprawl. Founded in 2016, Oryx received FDA 510(k) clearance for its imaging product in May 2022; by August 2026 it reported 62 employees, more than 15,000 clinicians and over 7 million patients supported, while ranking #863 on the Inc. 5000.
Oryx positions its price against Open Dental’s low entry cost by selling a bundled cloud service intended to displace separate infrastructure and add-on spend, making its value case total workflow cost rather than headline price. In 2026, Oryx’s plans started at $650 monthly; Open Dental’s first-year base was about $179 per location monthly, with hosting, plugins, and IT support adding to the stack, while Oryx’s offer bundled core capabilities.
That packaging favors offices seeking predictable procurement over buyers optimizing for the lowest base license or build-your-own customization. In June 2026, the Academy of General Dentistry offered Oryx to nearly 40,000 member dentists at preferred rates, extending reach through an established professional association.
Oryx’s key execution risk is whether rapid expansion can sustain implementation and service quality while the platform grows beyond its founder-led clinical roots. In August 2026 the company reported a 62-person team, over 15,000 clinicians, and support for more than 7 million patients; those scale indicators heighten the importance of reliable migration, support, and secure handling of clinical records as competitors such as Open Dental offer flexible deployments.
The premium bundle also leaves Oryx exposed if practices value Open Dental’s lower base price and customization more than integrated workflows. Oryx started at $650 monthly in 2026 versus Open Dental’s stated first-year base of about $179 per location monthly, while the June 2026 Academy of General Dentistry channel provides a distribution mitigant but does not by itself show conversion, retention, or pricing power.
Oryx’s subscription bundle may improve value capture by replacing separate imaging, communication, and practice tools, but its economics cannot be judged from price alone against Open Dental’s lower base license. In 2026, Oryx plans started at $650 monthly, while Open Dental’s stated first-year base was about $179 per location monthly before hosting, plugins, and IT support; the comparison identifies cost components but provides no realized gross margins or typical total-cost denominator.
Source: oryxdental.com
Source: oryxdental.com
Oryx’s apparent choice-cell is practices prioritizing integrated clinical consistency and reduced IT/vendor overhead, not buyers whose leading criterion is maximum customization or a low entry price. Open Dental starts at about $179 monthly per location for its first year, while Oryx uses bundled pricing; in June 2026 Oryx became the first dental practice-management platform recognized as an Academy of General Dentistry member-benefit provider, reaching an association of nearly 40,000 dentists.
Source: oryxdental.com
Source: oryxdental.com
Professional associations offer a route to reach buyers as practices modernize, while established alternatives retain customization or scale advantages. In June 2026, the Academy of General Dentistry offered Oryx as a member benefit to nearly 40,000 dentists, and the company also partnered with Seattle Study Club that year; sustained clinician growth and conversion from these channels would be the clearest confirmation of continued market momentum.
Source: oryxdental.com
The thesis depends on growth converting into customer economics and on clinical integration remaining meaningfully differentiated as alternatives expand cloud features. In June 2026 Oryx gained Academy of General Dentistry member-benefit access to nearly 40,000 dentists, but Open Dental retains open-source customization and a lower stated base price, about $179 per location monthly versus Oryx plans starting at $650 monthly in 2026; evidence of retention, margins and channel conversion would determine whether bundled value sustains premium pricing.
Source: oryxdental.com
Source: oryxdental.com
Source: oryxdental.com
A clinician base above 15,000 and more than 7 million patients supported by August 2026 suggest substantial workflow use, which could support recurring subscription value if practices remain on the system. Oryx’s 62 employees in 2026 and the 2022 FDA clearance for its imaging product indicate both ongoing service and regulated product responsibilities, but disclosed figures do not establish retention, revenue per location, infrastructure costs, or support cost per customer.
Source: oryxdental.com